Bogart Wealth LLC’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
F
Bogart Wealth LLC's NVO Position: Q2 2026 in Review
Bogart Wealth LLC increased its Novo Nordisk (NVO) stake by 3.2% in Q2 2026, buying an estimated $1.16K and bringing the position to 868 shares worth $41.6K. The position accounts for ﹤0.01% of the portfolio, ranked #587.
Bogart Wealth LLC first reported a position in NVO in Q1 2021 and has held it in 22 quarters since. The position peaked at $175K in Q2 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.
- Bogart Wealth LLC held 868 shares of Novo Nordisk worth $41.6K as of Q2 2026.
- Bogart Wealth LLC bought 27 Novo Nordisk shares in Q2 2026, an estimated $1.16K.
- Novo Nordisk made up ﹤0.01% of Bogart Wealth LLC's portfolio in Q2 2026, its #587 holding.
- Bogart Wealth LLC first reported a position in Novo Nordisk in Q1 2021 and has held it in 22 quarters since.
- Bogart Wealth LLC's Novo Nordisk position peaked at $175K in Q2 2024.
- 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.
Based on Bogart Wealth LLC's 13F filing for Q2 2026, filed 24 Jul 2026.